2 Day Masterclass in Biotech Negotiation and Deal Closing

An interactive course focused on determining your partnering strategy, understanding IP and licensing essentials, and creating financial models to structure and negotiate a deal that will help you achieve your strategic goals

Objectives | Your Trainer | Course Participants | How It Works

Course Objectives

• Define Your Strategy. Develop a clear partnering strategy, engage with the right partner, and understand the necessary due diligence for your approach.

• Master IP Concepts. Gain critical knowledge of intellectual property essential for effective deal-making.

• Structure Deals Effectively. Learn how to build a comprehensive deal structure using industry-standard approaches.

• Negotiate with Confidence. Achieve productive negotiations by constructing financial models with DCF (Discounted Cash Flow) that cover various scenarios and use them to finalize licensing terms.

• Understand Commercial Terms. Master the negotiation of commercial terms, especially with Big Pharma, and align your deal with your partner’s needs.

• Navigate the Process. Build confidence by understanding the stages of negotiation, from preparation to concluding deals, and learning business development strategies.

• Mitigate Risks. Be aware of post-negotiation risks and challenges, and how to effectively address them.

Dr. Simon Bennett is a seasoned professional with over 27 years of experience in the biopharma industry. He has held senior management roles in a range of businesses, from early-stage ventures to IPOs and trade sales, providing guidance and leadership across various sectors including biopharma, biotech, genomics, and specialty pharma.

Dr. Bennett manages a portfolio of companies and serves as a board director for Polku Therapeutics and Xobaderm, and is currently also Chief Business Officer at Avacta Group plc. He was a non-executive director at colwiz, supporting the company through to its acquisition by Informa plc. Earlier in his career, he was part of the executive team at Solexa until its acquisition by Illumina, Inc. He has also worked closely with leading organizations such as Bristol-Myers Squibb, Menarini, Beijing Tide Pharma amongst others, contributing to their business development strategies.

With a successful track record in commercial transactions, having completed over 80 deals globally, Dr. Bennett has worked alongside both Big Pharma and biotech companies, delivering strategic value to the teams he supports.

This 2-day Masterclass is perfect for Biotech and Pharma professionals ready to excel in deal negotiations.

Whether you’re in a Biotech company, Pharma firm, CDMO, or involved in licensing and marketing pharmaceuticals, this course will empower you with practical skills in deal structuring, IP essentials, and financial modelling.

Unlock the tools you need to secure successful partnerships and drive your business forward.

• Licensing Managers

• Portfolio Managers

• Commercial & Business Development Managers

• Alliance and Partnership Managers

• Heads of Strategy

• CEOs, CFOs and Board Members

• Investors

• Research and Development

• The 2 Day Masterclass is delivered live online.

• Course reminders, access passwords, digital course materials and slides will be sent out before the course.

• Course Timings: 9 - 4 pm (UK GMT/BST). Timings can be adjusted to suit your time zone.

• A Certificate of Participation will be given to each attendee.